一、本期业绩预计情况 1.业绩预告期间：2025年1月1日- 6月30日。 2.业绩预告情况：亏损 ■ 证券代码：000809 证券简称：和展能源 公告编号：2025-031 辽宁和展能源集团股份有限公司 2025年半年度业绩预告公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 二、与会计师事务所沟通情况 本次业绩预告未经注册会计师预审计。 三、业绩变动原因说明 1.公司本报告期亏损主要源于以下两点： 一是混塔项目所在地均位于北方，三月份才开始具备生产条件，同时由于买方机型调整，要求的混塔交 货时间推迟，公司生产的混塔未能按预期实现交付，本报告期未能实现混塔设备销售收入，其收入主要 来自于混塔预应力施工收入。截至6月30日，公司上半年已生产混塔产品25套，三季度将开始陆续交 付。 二是新能源业务尚处于开发核准建设阶段，未能形成收入。 2.本报告期较上年同期减亏25.75%-42.67%，主要源于以下两点： 一是由于公司于2024年末完成控股子公司铁岭财京投资有限公司重大资产出售，持股比例降至 38.68%，剥离了经营状况不佳的土地一级开发业务，按权益法计入 ...

Performance Forecast - The company expects a net loss attributable to shareholders of 30.5 to 39.5 million yuan for the first half of 2025, compared to a loss of 53.2 million yuan in the same period of 2024 [1] - The net loss after deducting non-recurring gains and losses is projected to be between 33.5 to 42.5 million yuan, down from a loss of 53.21 million yuan in the previous year [1] - Basic earnings per share are estimated to be a loss of 0.037 to 0.048 yuan per share, compared to a loss of 0.064 yuan per share in the prior year [1] Reasons for Performance Change - The delay in the delivery of mixed tower equipment due to production conditions and buyer model adjustments has resulted in no expected sales revenue from mixed tower equipment, with revenue primarily coming from pre-stressed construction income [1] - The company produced 25 sets of mixed tower products by June 30, 2025, with deliveries expected to begin in the third quarter [1] - The new energy business is still in the development and approval stage, which has not yet generated revenue [1] Asset Disposal Impact - The company completed a significant asset sale of its subsidiary, reducing its stake to 38.68%, which has led to a decrease in losses from the previously underperforming land development business [2] - The company has also generated some investment income from idle funds [2] Disclosure and Reporting - The performance forecast is based on preliminary calculations by the company's finance department, with detailed financial data to be disclosed in the 2025 semi-annual report [2] - The company will adhere to legal and regulatory requirements for timely information disclosure [2]

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

Core Viewpoint - The successful signing of the mixed tower order reflects the client's recognition of the company's product reliability, economic efficiency, and customization capabilities, enhancing the company's market reputation in the wind power tower sector [1][2] Group 1: Contract Details - The contract signed between Changhe Company and Beijing Puhua Sunshine Investment Co., Ltd. involves the procurement of 54 sets of 160m steel-concrete towers for the Mudanjiang Linkou 300MW wind power project, with a total contract value of 177.12 million yuan (including tax) [1] - The delivery of the signed mixed tower order is expected to occur between October 2025 and December 2026, positively impacting the financial status and operational results for 2025 and 2026 [2] Group 2: Production and Supply Plans - Changhe Company will commence site construction, mold design, and production preparations immediately, with plans to complete material stocking by August 2025 and to fulfill 30 sets of production tasks by November 2025 [1][2] - The company aims to enhance its market expansion capabilities and industry competitiveness through this order, striving for better and faster development of its mixed tower business to improve revenue and profitability [2]

Overview - The company, Liaoning Hezhan Energy Group Co., Ltd., provides a guarantee for its wholly-owned subsidiary, Liaoning Changhe Wind Power Equipment Co., Ltd., to secure a loan from Shanghai Pudong Development Bank, with a maximum principal amount of RMB 50 million [1][2]. Guarantee Details - The guarantee is for a loan amount of RMB 9.0304 million, with a loan term from June 25, 2025, to June 24, 2026 [2]. - The total guarantee amount provided by the company for its subsidiaries in 2025 is capped at RMB 50 million, and this specific guarantee falls within that limit [2][4]. - After this guarantee, the company's total guarantee balance for Changhe Wind Power is RMB 9.0304 million, leaving a usable guarantee amount of RMB 40.9696 million [2]. Financial Situation of the Subsidiary - As of the end of March 2025, Changhe Wind Power's total assets were RMB 44.50832 million, with total liabilities of RMB 39.19745 million, resulting in a net asset value of RMB 5.31087 million [3]. - The asset-liability ratio for Changhe Wind Power was reported at 88.07% [3]. - The subsidiary's revenue for the first quarter of 2025 was RMB 0.8008 million, with a net loss of RMB 0.9724 million [3]. Contractual Obligations - The guarantee is a joint liability guarantee, meaning that if the subsidiary fails to meet its obligations, the company is liable for the debt without requiring other guarantees to be fulfilled first [4][5]. - The guarantee period extends three years beyond the maturity of each loan [5]. Board's Opinion - The board believes that providing this guarantee is essential for the operational needs of Changhe Wind Power and will not adversely affect the company's normal operations or the interests of shareholders, particularly minority shareholders [6]. Cumulative Guarantee Information - As of the announcement date, the total guarantee amount by the company and its subsidiaries is RMB 9.0304 million, which is 0.33% of the company's latest audited net assets [6]. - There are no overdue guarantees or guarantees involved in litigation as of the current date [6].

6月30日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者参 考。 【品大事】 冠昊生物：深交所终止对公司再融资的审核 冠昊生物(300238)公告，6月23日，公司和保荐机构银河证券向深交所提交了申请，申请撤回向特定对 象发行股票申请文件。近日，公司收到深交所出具的《决定》，深交所决定终止对公司申请向特定对象 发行股票的审核。 奥瑞德：算力租赁服务业绩存在重大不确定性 奥瑞德(600666)发布股票交易异常波动公告称，公司向客户提供算力租赁服务，收取算力租赁服务费。 该业务需进行重资产投入，投资金额较大，后续经营过程中算力租赁服务价格可能受宏观经济及行业政 策变化、技术迭代、市场竞争等多重不确定因素影响而发生波动，业绩存在重大不确定性。 金鸿顺(603922)公告，公司筹划以发行股份及支付现金的方式购买新思考电机有限公司95.79%的股权同 时募集配套资金。自筹划上述重大资产重组事项以来，交易各方对交易方案进行了多次协商，但未能就 最终方案达成一致。经协商，同意终止此次重大资产重组事项。 合金投资：控股股东拟变更为九洲恒昌 股票明起复牌 合金投资(000633)公告，公司控股 ...

辽宁和展能源集团股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 证券代码：000809 证券简称：和展能源 公告编号：2025-029 本次担保为公司对资产负债率超过 70%的全资子公司提供的担保，敬请投资 者关注担保风险。 一、担保情况概述 为满足业务发展需要，辽宁和展能源集团股份有限公司（以下简称"公司"） 二级全资子公司辽宁昌和风电设备有限公司（以下简称"昌和风电"）向上海浦 东发展银行股份有限公司铁岭分行（以下简称"浦发银行"）申请不超过人民币 8,000 万元授信。2025 年 6 月 30 日，公司与浦发银行签署《最高额保证合同》， 公司为昌和风电向浦发银行在 2025 年 6 月 25 日至 2026 年 6 月 24 日期间内办理 各类融资业务以本金余额最高不超过人民币 5,000 万元为限提供连带责任保证 担保，公司对债权发生期间内各单笔借款合同项下分期履行的还款义务承担保证 责任，保证期间为自每笔债权合同债务履行期届满之日起至该单笔合同最后一期 还款期限届满之日后三年。 2025 ...

本次签署的混塔订单预计在 2025 年 10 月至 2026 年 12 月期间进行交付，将 对 2025 年和 2026 年的财务状况和经营成果产生积极影响，将有效支撑公司业绩 目标。 在合同履约期间，采购方可能依据业主的需要对合同工作内容、供货数量、 设备价格、交货时间进行相应的调整，双方将根据情况协商完成合同工作内容的 1 证券代码：000809 证券简称：和展能源 公告编号：2025-030 辽宁和展能源集团股份有限公司 关于全资子公司签订钢混塔架销售合同的自愿性信息披露公告 本公司及董事会全体成员保证信息披露的内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 2025 年 6 月 27 日，辽宁和展能源集团股份有限公司（以下简称"公司"） 二级全资子公司辽宁昌和风电设备有限公司（以下简称"昌和公司"）作为供货 方与采购方北京普华阳光投资有限公司签订《牡丹江林口 300MW 风力发电项目钢 混塔架采购合同》。合同标的物为 54 套 160m 钢混塔架，合同总价款为 17,712 万元（含税）。 按照上述风力发电项目的并网时间及采购方对钢混塔架的预计需求时间，根 据工程进度要求，昌和公司依据自 ...

和展能源（000809）公告，2025年6月27日，二级全资子公司辽宁昌和风电设备有限公司与北京普华阳 光投资有限公司签订《牡丹江林口300MW风力发电项目钢混塔架采购合同》。合同标的物为54套160m 钢混塔架，总价款为1.77亿元(含税)。昌和公司将计划2025年8月前完成物资备货并开始生产，2025年11 月前完成30套生产任务。该订单预计在2025年10月至2026年12月期间交付，将对公司2025年和2026年的 财务状况和经营成果产生积极影响。 ...

酒行业丨市场观察 本周看点： -精酿啤酒渠道热，白酒经销商为何冷淡？ -白酒巨头抢夺香港市场； -淡季里的热战，酒业掀起"请进来"运动。 行业环境 1.精酿啤酒掀起渠道热，为何传统白酒经销商态度冷淡？ 关键词 ： 精酿啤酒,即时零售,渠道布局,消费热度,市场增长 概要 ： 精酿啤酒市场热度上升，渠道态度分化。即时零售推动下，部分酒类零售商布局精酿 实现显著增长，如河南连锁品牌销量增20%-35%；但传统白酒经销商多持观望态度，因保质期 短、供应链经验不足等原因。尽管如此，精酿作为"流量+利润"产品吸引部分酒商尝试，但市 场同质化严重、品牌化不足。未来，头部品牌的出现及新零售入局或成行业关键看点。 2.精准卡位30-60元价格带、在江苏多地热销，"川味"巴适开启全国化布局 关键词 ： 光瓶酒,巴适文化,白酒市场,渠道策略,品质追求 概要 ： 光瓶酒市场预计2024年达1500亿，未来十年或突破2000亿。四川春泉集团推出的"巴 适"光瓶酒，以高性价比和品质化在江苏市场崭露头角，主力产品精准切入30-60元价格带。依 托邛崃优质酿酒资源与传统工艺，"巴适"融合国潮设计，满足怀旧与年轻化需求。厂家提供灵 活渠道政策 ...